A preliminary study of finasteride in Tourette syndrome

Movement Disorders

Volumn 26, Issue 11, 2011, Pages 2146-2147

  Muroni, Antonella ^a   Paba, Silvia ^a   Puligheddu, Monica ^a   Marrosu, Francesco ^a   Bortolato, Marco ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; FINASTERIDE; PIMOZIDE;

ADULT; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; ENDOCRINE DISEASE; GILLES DE LA TOURETTE SYNDROME; HUMAN; LETTER; LIBIDO DISORDER; MALE; MENTAL DISEASE; METABOLIC DISORDER; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PENIS ERECTION; PRIORITY JOURNAL; SIDE EFFECT;

5-ALPHA REDUCTASE INHIBITORS; ADOLESCENT; ADULT; FEMALE; FINASTERIDE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TIME FACTORS; TOURETTE SYNDROME; YOUNG ADULT;

EID: 80052969290     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23810     Document Type: Letter

References (7)

1. Paba S, Frau R, Godar SC, Devoto P, Marrosu F, Bortolato M. Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders. Curr Pharm Des 2011; 17: 151-167.
2. Bortolato M, Muroni A, Marrosu F. Treatment of Tourette's syndrome with finasteride. Am J Psychiatry 2007; 164: 1914-1915.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DMS-IV-TR). Washington, DC: American Psychiatric Association; 2000.
4. Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989; 28: 566-573.
5. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011.
6. Peterson BS, Leckman JF, Scahill L, et al. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology 1992; 17: 553- 563.
7. Leckman JF, Scahill L. Possible exacerbation of tics by androgenic steroids. N Engl J Med 1990; 322: 1674.